AI Verdict
RBRK has stronger fundamentals based on our AI analysis.
RCUS vs RBRK Fundamental Comparison
| Metric | RCUS | RBRK |
|---|---|---|
| Revenue | $247.0M | $1.3B |
| Net Income | $-353.0M | $-348.8M |
| Net Margin | -142.9% | -26.5% |
| ROE | -55.9% | N/A |
| ROA | -31.0% | -12.6% |
| Current Ratio | 4.36x | 1.69x |
| Debt/Equity | 0.16x | N/A |
| EPS | $-3.29 | $-1.78 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
RCUS vs RBRK: Frequently Asked Questions
Is RCUS or RBRK a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), RBRK has stronger fundamentals. RCUS is rated SELL (78% confidence) while RBRK is rated BUY (70% confidence). This is not investment advice.
How does RCUS compare to RBRK fundamentally?
Arcus Biosciences, Inc. has ROE of -55.9% vs Rubrik, Inc.'s N/A. Net margins are -142.9% vs -26.5% respectively.
Which stock pays higher dividends, RCUS or RBRK?
RCUS has a dividend yield of N/A or no dividend while RBRK has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in RCUS or RBRK for long term?
For long-term investing, consider that RCUS has SELL rating with 78% confidence, while RBRK has BUY rating with 70% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about RCUS vs RBRK?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For RCUS vs RBRK, the AI consensus favors RBRK based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.